Weight management/Probiotics Premix/500B
Shelf life: 24 months
Storage conditions: Stored at -18℃ or lower
Main Strains
√ Lactiplantibacillus plantarumF3-2
√ Lactiplantibacillus plantarumH-87
√ Lactiplantibacillus plantarumYZX21
√ Lacticaseibacillus caseiYRL577
√ Lacticaseibacillus paracasei G15
√ Bifidobacterium animalis subsp. lactis BA-C53
Shelf life: 24 months
Storage conditions: Stored at -18℃or below
Health Benefits:
√ Lower body weight and BMI
√ Reduce waist circumference
√ Reduce visceral fat
√ Relieve high fat diet-induced obesity
√ Reduce your food intake
The advantages of probiotics in fat-lowering
Experiment on Bifidobacterium animalis subsp. lactics F1-7 and Lactiplantibacillus plantarum YZX21
Conclusion:
F1-7 and YZX21 increase the level of GLP-1, thus promoting the secretion of insulin in the body, and up-regulate glucagon gene, regulate blood sugar bidirectional, and relieve the phenomenon of hyperglycemia or hypoglycemia.
Lactiplantibacillus plantarum F3-2 showed significant improvement in body fat

The data presented in the figure indicates that after a period of feeding, the body weight of mice in the high-fat diet groupsignificantly increased compared to the control group. In contrast, the weight gain observed in mice subjected to Lactiplantibacillus plantarum F3-2 intervention was markedly lower than that of the high-fat diet group. This clearly demonstrates the positive
regulatory effect of Lactiplantibacillus plantarum F3-2 on obesity induced by a high-fat diet.
Reference: Lactiplantibacillus plantarum F3-2 and mannooligosaccharides alleviated the obesity of mice through up-regulating SCFAs and inhibiting PPARγ
Reduce the size of fat cells and relieve excessive fat accumulation
Experimental Study on Lactiplantibacillus plantarum F3-2
Conclusion:
Probiotic Group - Significant Reduction in Adipocyte Volume
Following the intervention with Lactiplantibacillusplantarum F3-2, the morphology of epididymaladipocytes in mice improved, with a notable decrease incell size and an increase in the number of smaller cells.
The average area of epididymal adipocytes in theLactiplantibacillus F3-2 intervention group wassignificantly reduced compared to the NC group (p <0.05), and there was no significant difference whencompared to the orlistat group (p > 0.05)
Reduce intra-abdominal fat, improve fatty liver conditions, and enhance hepatic glucose metabolism
Experimental Study on Lactiplantibacillus plantarum F3-2
NC: Control group HFD: High-fat diet group OR: Orlistat group Plant F3-2: Probiotic group

Conclusion:
F3-2, repairs fatty liver andrestores hepatic lipid-processingfunction, similar to the positivedrug orlistat.
F3-2, repairs fatty liver andrestores hepatic lipid-processingfunction, similar to the positivedrug orlistat.
H-87 inhibits the enlargement of adipocytes and reduces body fat
Low-fat diet feeding group (LFD), high-fat diet feeding group (HFD), probiotic + high
fat diet group (H-87)

Experimental Study on Lactiplantibacillus plantarum H-87
H-87 can mitigate weight gain, fat accumulation, and hyperlipidemiainduced by a high-fat diet without suppressing food intake:
(a) H-87 effectively slows down weight gain.
(b) The food intake between the high-fat diet group and the high-fatdiet + H-87 group is approximately the same.
(c) The adipocyte size in mice on a high-fat diet is significantly largerthan that in mice on a low-fat diet, while H-87 supplementation cansignificantly inhibit the increase in adipocyte size.
(d) The weights of the three main white adipose tissues (eWAT,pWAT, and iWAT) in mice on a high-fat diet are significantlyincreased, whereas H-87 can effectively suppress weight gain in thesemice.
(e) H-87 supplementation can significantly reduce serum triglycerideand LDL levels.
H-87 reduces liver lipogenesis

Experimental Study on Lactiplantibacillus plantarum H-87
Low-fat diet fed group (LFD), high-fat diet fed group (HFD),
probiotics + high-fat diet group (H-87) A high-fat diet significantly increases liver weight and
triglyceride (TG) levels, while H-87 supplementation can markedly reduce liver weight, liver TG, and cholesterol (CHOL) in mice subjected to a high-fat diet, thereby
decreasing hepatic fat accumulation.

